|
2026-10-16 |
2026-10-15 |
S
Sale
|
Chief Executive Officer
Executive Director
|
42,972
+29.5%
138.38
US$226,212
|
42,972
+29.5%
|
138.38
|
US$226,212
|
|
|
2026-10-16 |
2026-10-15 |
S
Sale
|
General Counsel
Officer
|
86,868
-47.7%
167.78
US$1,388,421
|
86,868
-47.7%
|
167.78
|
US$1,388,421
|
|
|
2026-10-16 |
2026-10-15 |
S
Sale
|
Chief Scientific Officer
Officer
|
75,228
-33.4%
51.69
US$4,584,259
|
75,228
-33.4%
|
51.69
|
US$4,584,259
|
|
|
2026-10-16 |
2026-10-15 |
S
Sale
|
CAO and Interim CFO
Officer
|
10,167
-6.7%
8.08
US$82,149
|
10,167
-6.7%
|
8.08
|
US$82,149
|
|
|
2026-10-16 |
2026-10-15 |
S
Sale
|
Chief Discovery Officer
Officer
|
12,248
-6.8%
7.84
US$96,024
|
12,248
-6.8%
|
7.84
|
US$96,024
|
|
|
2026-10-16 |
2026-10-15 |
S
Sale
|
Chief Medical Officer
Officer
|
15,355
-4.9%
8.08
US$124,068
|
15,355
-4.9%
|
8.08
|
US$124,068
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
9,020
7.81
US$70,446
|
9,020
|
7.81
|
US$70,446
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
10,167
7.81
US$79,404
|
10,167
|
7.81
|
US$79,404
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
15,355
7.81
US$119,922
|
15,355
|
7.81
|
US$119,922
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
73,691
7.81
US$575,527
|
73,691
|
7.81
|
US$575,527
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
11,513
7.81
US$89,917
|
11,513
|
7.81
|
US$89,917
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
14,809
7.81
US$115,658
|
14,809
|
7.81
|
US$115,658
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
12,500
7.81
US$97,625
|
12,500
|
7.81
|
US$97,625
|
|
|
2026-09-18 |
2026-09-16 |
PlS
Planned sale
|
General Counsel
Officer
|
16,509
-10.8%
11.67
US$192,660
|
16,509
-10.8%
|
11.67
|
US$192,660
|
|
|
2026-09-16 |
2026-09-16 |
PrS
Proposed sale
|
Officer
Officer
|
16,509
12.08
US$199,429
|
16,509
|
12.08
|
US$199,429
|
|
|
2026-08-18 |
2026-08-14 |
B
Purchase
|
Large shareholder
|
4,400,000
+21.0%
11.38
US$50,072,000
|
4,400,000
+21.0%
|
11.38
|
US$50,072,000
|
|
|
2026-08-04 |
2026-08-03 |
PlS
Planned sale
|
Chief Scientific Officer
Officer
|
22,082
-9.8%
12.54
US$276,908
|
22,082
-9.8%
|
12.54
|
US$276,908
|
|
|
2026-08-03 |
2026-08-03 |
PrS
Proposed sale
|
Officer
Officer
|
22,082
13.02
US$287,508
|
22,082
|
13.02
|
US$287,508
|
|
|
2026-08-03 |
2026-08-03 |
PrS
Proposed sale
|
Officer
Officer
|
22,082
13.02
US$287,508
|
22,082
|
13.02
|
US$287,508
|
|
|
2026-07-30 |
2026-07-30 |
PrS
Proposed sale
|
Former Affiliate
|
1,600,000
15.02
US$24,032,000
|
1,600,000
|
15.02
|
US$24,032,000
|
|
|
2026-07-30 |
2026-07-30 |
B
Purchase
|
Large shareholder
|
1,000,000
+5.0%
13.00
US$13,000,000
|
1,000,000
+5.0%
|
13.00
|
US$13,000,000
|
|
|
2026-07-30 |
2026-07-29 |
B
Purchase
|
Large shareholder
|
3,000
+0.0%
12.63
US$37,890
|
3,000
+0.0%
|
12.63
|
US$37,890
|
|
|
2026-07-30 |
2026-07-28 |
B
Purchase
|
Large shareholder
|
65,137
+0.3%
11.69
US$761,393
|
65,137
+0.3%
|
11.69
|
US$761,393
|
|
|
2026-07-30 |
2026-07-28 |
B
Purchase
|
Large shareholder
|
141,088
+0.7%
10.74
US$1,515,511
|
141,088
+0.7%
|
10.74
|
US$1,515,511
|
|
|
2026-07-28 |
2026-07-28 |
B
Purchase
|
Non-Executive Director
|
15,620
New position
9.52
US$148,702
|
15,620
New position
|
9.52
|
US$148,702
|
|
|
2026-07-20 |
2026-07-17 |
PlS
Planned sale
|
Chief Discovery Officer
Officer
|
200
-0.1%
38.39
US$7,678
|
200
-0.1%
|
38.39
|
US$7,678
|
|
|
2026-07-20 |
2026-07-17 |
PlS
Planned sale
|
Chief Discovery Officer
Officer
|
14,140
-7.5%
37.70
US$533,078
|
14,140
-7.5%
|
37.70
|
US$533,078
|
|
|
2026-07-20 |
2026-07-17 |
PlS
Planned sale
|
Chief Discovery Officer
Officer
|
2,833
-1.5%
37.05
US$104,963
|
2,833
-1.5%
|
37.05
|
US$104,963
|
|
|
2026-07-20 |
2026-07-17 |
PlS
Planned sale
|
CAO and Interim CFO
Officer
|
900
-0.6%
38.17
US$34,353
|
900
-0.6%
|
38.17
|
US$34,353
|
|
|
2026-07-20 |
2026-07-17 |
PlS
Planned sale
|
CAO and Interim CFO
Officer
|
16,969
-10.5%
37.61
US$638,204
|
16,969
-10.5%
|
37.61
|
US$638,204
|
|
|
2026-07-20 |
2026-07-17 |
PlS
Planned sale
|
CAO and Interim CFO
Officer
|
600
-0.4%
36.51
US$21,906
|
600
-0.4%
|
36.51
|
US$21,906
|
|
|
2026-07-17 |
2026-07-17 |
S
Sale
|
Chief Executive Officer
Executive Director
|
16,779
-1.3%
37.90
US$635,924
|
16,779
-1.3%
|
37.90
|
US$635,924
|
|
|
2026-07-17 |
2026-07-17 |
S
Sale
|
Chief Scientific Officer
Officer
|
2,077
-0.9%
37.90
US$78,718
|
2,077
-0.9%
|
37.90
|
US$78,718
|
|
|
2026-07-17 |
2026-07-17 |
S
Sale
|
General Counsel
Officer
|
1,130
-0.8%
37.90
US$42,827
|
1,130
-0.8%
|
37.90
|
US$42,827
|
|
|
2026-07-17 |
2026-07-17 |
S
Sale
|
Chief Medical Officer
Officer
|
3,656
-1.2%
37.90
US$138,562
|
3,656
-1.2%
|
37.90
|
US$138,562
|
|
|
2026-07-17 |
2026-07-17 |
PrS
Proposed sale
|
Officer
Officer
|
17,173
37.22
US$639,179
|
17,173
|
37.22
|
US$639,179
|
|
|
2026-07-17 |
2026-07-17 |
PrS
Proposed sale
|
Officer
Officer
|
18,469
37.22
US$687,416
|
18,469
|
37.22
|
US$687,416
|
|
|
2026-07-20 |
2026-07-16 |
S
Sale
|
Chief Discovery Officer
Officer
|
1,592
-0.8%
37.44
US$59,604
|
1,592
-0.8%
|
37.44
|
US$59,604
|
|
|
2026-07-20 |
2026-07-16 |
S
Sale
|
Chief Discovery Officer
Officer
|
7,464
-3.7%
36.66
US$273,630
|
7,464
-3.7%
|
36.66
|
US$273,630
|
|
|
2026-07-20 |
2026-07-16 |
S
Sale
|
CAO and Interim CFO
Officer
|
1,476
-0.9%
37.44
US$55,261
|
1,476
-0.9%
|
37.44
|
US$55,261
|
|
|
2026-07-20 |
2026-07-16 |
S
Sale
|
CAO and Interim CFO
Officer
|
6,979
-4.1%
36.66
US$255,850
|
6,979
-4.1%
|
36.66
|
US$255,850
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Executive Officer
Executive Director
|
92
-0.0%
37.96
US$3,492
|
92
-0.0%
|
37.96
|
US$3,492
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Executive Officer
Executive Director
|
28,091
-2.2%
37.26
US$1,046,671
|
28,091
-2.2%
|
37.26
|
US$1,046,671
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Executive Officer
Executive Director
|
40,899
-3.1%
36.46
US$1,491,178
|
40,899
-3.1%
|
36.46
|
US$1,491,178
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Scientific Officer
Officer
|
12
-0.0%
37.96
US$456
|
12
-0.0%
|
37.96
|
US$456
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Scientific Officer
Officer
|
3,526
-1.5%
37.26
US$131,379
|
3,526
-1.5%
|
37.26
|
US$131,379
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Scientific Officer
Officer
|
5,009
-2.1%
36.45
US$182,578
|
5,009
-2.1%
|
36.45
|
US$182,578
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
General Counsel
Officer
|
11
-0.0%
37.96
US$418
|
11
-0.0%
|
37.96
|
US$418
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
General Counsel
Officer
|
3,331
-2.2%
37.26
US$124,113
|
3,331
-2.2%
|
37.26
|
US$124,113
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
General Counsel
Officer
|
4,776
-3.1%
36.45
US$174,085
|
4,776
-3.1%
|
36.45
|
US$174,085
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Medical Officer
Officer
|
19
-0.0%
37.96
US$721
|
19
-0.0%
|
37.96
|
US$721
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Medical Officer
Officer
|
5,865
-1.9%
37.26
US$218,530
|
5,865
-1.9%
|
37.26
|
US$218,530
|
|
|
2026-07-17 |
2026-07-16 |
S
Sale
|
Chief Medical Officer
Officer
|
9,163
-2.9%
36.46
US$334,083
|
9,163
-2.9%
|
36.46
|
US$334,083
|
|
|
2026-07-20 |
2026-07-15 |
S
Sale
|
Chief Discovery Officer
Officer
|
4,510
-2.2%
36.94
US$166,599
|
4,510
-2.2%
|
36.94
|
US$166,599
|
|
|
2026-07-20 |
2026-07-15 |
S
Sale
|
Chief Discovery Officer
Officer
|
5,545
-2.6%
36.13
US$200,341
|
5,545
-2.6%
|
36.13
|
US$200,341
|
|
|
2026-07-20 |
2026-07-15 |
S
Sale
|
CAO and Interim CFO
Officer
|
4,699
-2.7%
36.94
US$173,581
|
4,699
-2.7%
|
36.94
|
US$173,581
|
|
|
2026-07-20 |
2026-07-15 |
S
Sale
|
CAO and Interim CFO
Officer
|
5,356
-3.0%
36.13
US$193,512
|
5,356
-3.0%
|
36.13
|
US$193,512
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Executive Officer
Executive Director
|
90
-0.0%
37.54
US$3,379
|
90
-0.0%
|
37.54
|
US$3,379
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Executive Officer
Executive Director
|
42,738
-3.1%
36.99
US$1,580,879
|
42,738
-3.1%
|
36.99
|
US$1,580,879
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Executive Officer
Executive Director
|
18,950
-1.4%
36.00
US$682,200
|
18,950
-1.4%
|
36.00
|
US$682,200
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Scientific Officer
Officer
|
12
-0.0%
37.54
US$450
|
12
-0.0%
|
37.54
|
US$450
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Scientific Officer
Officer
|
5,393
-2.2%
36.99
US$199,487
|
5,393
-2.2%
|
36.99
|
US$199,487
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Scientific Officer
Officer
|
2,238
-0.9%
36.00
US$80,568
|
2,238
-0.9%
|
36.00
|
US$80,568
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
General Counsel
Officer
|
10
-0.0%
37.54
US$375
|
10
-0.0%
|
37.54
|
US$375
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
General Counsel
Officer
|
5,103
-3.2%
36.99
US$188,760
|
5,103
-3.2%
|
36.99
|
US$188,760
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
General Counsel
Officer
|
2,147
-1.3%
36.00
US$77,292
|
2,147
-1.3%
|
36.00
|
US$77,292
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Medical Officer
Officer
|
18
-0.0%
37.54
US$676
|
18
-0.0%
|
37.54
|
US$676
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Medical Officer
Officer
|
8,972
-2.7%
36.99
US$331,874
|
8,972
-2.7%
|
36.99
|
US$331,874
|
|
|
2026-07-17 |
2026-07-15 |
S
Sale
|
Chief Medical Officer
Officer
|
4,465
-1.3%
36.00
US$160,740
|
4,465
-1.3%
|
36.00
|
US$160,740
|
|
|
2026-07-17 |
2026-07-15 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
7,845
-2.3%
37.04
US$290,579
|
7,845
-2.3%
|
37.04
|
US$290,579
|
|
|
2026-07-17 |
2026-07-15 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
7,155
-2.1%
36.16
US$258,725
|
7,155
-2.1%
|
36.16
|
US$258,725
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
36,284
37.91
US$1,375,526
|
36,284
|
37.91
|
US$1,375,526
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
36,979
37.91
US$1,401,874
|
36,979
|
37.91
|
US$1,401,874
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
33,605
37.91
US$1,273,966
|
33,605
|
37.91
|
US$1,273,966
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
48,158
37.91
US$1,825,670
|
48,158
|
37.91
|
US$1,825,670
|
|